Data from patients outside the United States are acceptable to use for this funding announcement if applicants demonstrate that the patient populations and patterns of drug use are applicable to the United States population. For further information on PCORI's foreign organization eligibility, please see this reference: https://help.pcori.org/hc/en-us/articles/202901800-Are-foreign-organizations-eligible-for-funding.
Does data included in the analysis need to be solely from patients in the United States?
Have more questions? Submit a request